Latest filing published 29 Jun 2026 for CG Oncology, Inc., €21.8M.
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Brian Guan-Chyun Liu appears in our data through filings on CG Oncology, Inc. shares, published by SEC (Form 4). The record holds 2 filings, for trades running from 11 September 2025 to 25 June 2026.
Purchases make up the whole of the open-market record (2 purchases, €64.4M). A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2026 to date brings 1 purchase and no sales.
The newest entry dates from 29 June 2026: an open-market purchase of €21.8M, in CG Oncology, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations